Literature DB >> 176664

Superinfection epithelial nasopharyngeal carcinoma cells with Epstein-Barr virus.

R Glaser, G de Thé, G Lenoir, J H Ho.   

Abstract

Attempts were made to superinfect epithelial explant cell cultures prepared from nasopharyngeal carcinomas with Epstein-Barr virus. Virus-specific markers were observed in such cultures 3 days after superinfection. In addition, expression of Epstein-Barr virus early antigens was observed in epithelial cell explant cultures treated with iododeoxyuridine. The results suggest that epithelial cells of at least certain nasopharyngeal carcinomas possess the receptor for the Epstein-Barr virus and that the latent virus genome can be induced from epithelial cells prepared from such tumors.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 176664      PMCID： PMC336040          DOI： 10.1073/pnas.73.3.960

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


  20 in total

1.  Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms, and control groups.

Authors:  W Henle; G Henle; H C Ho; P Burtin; Y Cachin; P Clifford; A de Schryver; G de-Thé; V Diehl; G Klein
Journal:  J Natl Cancer Inst       Date:  1970-01       Impact factor: 13.506

2.  Nasopharyngeal carcinoma. IX. Antibodies to EBNA and correlation with response to other ebv antigens in chinese patients.

Authors:  G de-Thé; J H Ho; D V Ablashi; N E Day; A J Macario; M C Martin-Berthelon; G Pearson; R Sohier
Journal:  Int J Cancer       Date:  1975-11-15       Impact factor: 7.396

3.  Nasopharyngeal carcinoma. X. Presence of epstein-barr genomes in separated epithelial cells of tumours in patients from Singapore, Tunisia and Kenya.

Authors:  C Desgranges; H Wolf; G De-Thé; K Shanmugaratnam; N Cammoun; R Ellouz; G Klein; K Lennert; N Muñoz; H Zur Hausen
Journal:  Int J Cancer       Date:  1975-07-15       Impact factor: 7.396

Review 4.  Evidence for an oncogenic potential of the Epstein-Barr virus.

Authors:  W Henle; G Henle
Journal:  Cancer Res       Date:  1973-06       Impact factor: 12.701

5.  Prolonged oropharyngeal excretion of Epstein-Barr virus after infectious mononucleosis.

Authors:  G Miller; J C Niederman; L L Andrews
Journal:  N Engl J Med       Date:  1973-02-01       Impact factor: 91.245

6.  Hybridization of Burkitt lymphoblastoid cells.

Authors:  R Glaser; F J O'Neill
Journal:  Science       Date:  1972-06-16       Impact factor: 47.728

7.  EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx.

Authors:  H zur Hausen; H Schulte-Holthausen; G Klein; W Henle; G Henle; P Clifford; L Santesson
Journal:  Nature       Date:  1970-12-12       Impact factor: 49.962

8.  Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines.

Authors:  B M Reedman; G Klein
Journal:  Int J Cancer       Date:  1973-05       Impact factor: 7.396

9.  Demonstration of Epstein-Barr virus-associated nuclear antigen in nasopharyngeal carcinoma cells from fresh biopsies.

Authors:  D P Huang; J H Ho; W Henle; G Henle
Journal:  Int J Cancer       Date:  1974-11-15       Impact factor: 7.396

10.  Rescue of Epstein-Barr virus from somatic cell hybrids of Burkitt lymphoblastoid cells.

Authors:  R Glaser; F Rapp
Journal:  J Virol       Date:  1972-08       Impact factor: 5.103
View more
  19 in total

1.  The mechanism of Epstein-Barr virus infection in nasopharyngeal carcinoma cells.

Authors:  C T Lin; C R Lin; G K Tan; W Chen; A N Dee; W Y Chan
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

Review 2.  Epstein-Barr virus tissue tropism: a major determinant of immunopathogenesis.

Authors:  L Hutt-Fletcher
Journal:  Springer Semin Immunopathol       Date:  1991

3.  Epstein-Barr virus infection of epithelial cells derived from primary cultures of adenoidal tissue.

Authors:  M Furukawa; H Sakashita; C Kato; R Umeda
Journal:  Eur Arch Otorhinolaryngol       Date:  1990       Impact factor: 2.503

4.  Epstein-Barr virus infection of human gastric carcinoma cells: implication of the existence of a new virus receptor different from CD21.

Authors:  H Yoshiyama; S Imai; N Shimizu; K Takada
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

5.  Two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus that were derived from nasopharyngeal carcinomas.

Authors:  R Glaser; H Y Zhang; K T Yao; H C Zhu; F X Wang; G Y Li; D S Wen; Y P Li
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

6.  Epstein-Barr virus (EBV)-containing nasopharyngeal carcinoma cells express the B-cell activation antigen blast2/CD23 and low levels of the EBV receptor CR2.

Authors:  M Billaud; P Busson; D Huang; N Mueller-Lantzch; G Rousselet; O Pavlish; H Wakasugi; J M Seigneurin; T Tursz; G M Lenoir
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

7.  Sendai virus envelopes can mediate Epstein-Barr virus binding to and penetration into Epstein-Barr virus receptor-negative cells.

Authors:  R Khélifa; J Menezes
Journal:  J Virol       Date:  1983-04       Impact factor: 5.103

8.  Enhanced oncogenic behavior of human and mouse cells after cellular hybridization with Burkitt tumor cells.

Authors:  R Glaser; D V Ablashi; M Nonoyama; W Henle; J Easton
Journal:  Proc Natl Acad Sci U S A       Date:  1977-06       Impact factor: 11.205

9.  Induction of Epstein-Barr virus nuclear antigen and DNA synthesis in a human epithelial cell line after Epstein-Barr virus infection.

Authors:  H Ben-Bassat; S Mitrani-Rosenbaum; N Goldblum
Journal:  J Virol       Date:  1982-02       Impact factor: 5.103

10.  Epstein-Barr virus-lymphoid cell interactions. III. Effect of concanavalin A and saccharides on Epstein-Barr virus penetration.

Authors:  R Khélifa; J Menezes
Journal:  J Virol       Date:  1982-05       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.